> top > docs > PMC:7205724 > spans > 1763-2958 > annotations

PMC:7205724 / 1763-2958 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
84 281-290 Species denotes 2019-nCoV Tax:2697049
85 381-387 Species denotes humans Tax:9606
86 442-450 Species denotes children Tax:9606
87 461-467 Species denotes people Tax:9606
88 57-65 Disease denotes COVID-19 MESH:C000657245
89 155-163 Disease denotes COVID-19 MESH:C000657245
98 881-889 Species denotes patients Tax:9606
99 927-935 Species denotes patients Tax:9606
100 903-922 Chemical denotes lopinavir-ritonavir MESH:C558899
101 748-756 Disease denotes COVID-19 MESH:C000657245
102 830-838 Disease denotes COVID-19 MESH:C000657245
103 994-999 Disease denotes death MESH:D003643
104 1112-1120 Disease denotes COVID-19 MESH:C000657245
105 1186-1194 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T8 198-204 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T9 326-332 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T21 57-65 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T22 155-163 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T23 748-756 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T24 830-838 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T25 1112-1120 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T26 1186-1194 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T8 381-387 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T9 476-477 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T10 550-551 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T11 618-624 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T12 641-642 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T13 758-759 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T14 1019-1024 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T15 1025-1029 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T9 694-711 Chemical denotes anti-viral agents http://purl.obolibrary.org/obo/CHEBI_22587
T10 903-922 Chemical denotes lopinavir-ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T11 903-912 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T12 913-922 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T4 1019-1024 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T8 903-922 Chemical denotes lopinavir-ritonavir http://purl.obolibrary.org/obo/CHEBI_145924

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T21 57-65 Species denotes COVID-19 NCBItxid:2697049
T22 155-163 Species denotes COVID-19 NCBItxid:2697049
T23 281-290 Species denotes 2019-nCoV NCBItxid:2697049
T24 381-387 Species denotes humans NCBItxid:9605
T25 748-756 Species denotes COVID-19 NCBItxid:2697049
T26 830-838 Species denotes COVID-19 NCBItxid:2697049
T27 1078-1088 Species denotes indicators NCBItxid:189528
T28 1112-1120 Species denotes COVID-19 NCBItxid:2697049
T29 1186-1194 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T28 1050-1195 Sentence denotes Here we review intermediate indicators of the pathogenesis of COVID-19 that have the potential of being considered for the treatment of COVID-19.
T21 0-15 Sentence denotes 1 Introduction
T22 16-139 Sentence denotes Several generations have been exposed to COVID-19 under different conditions of life at varying locations around the world.
T23 140-246 Sentence denotes As long as the COVID-19 continues to spread, its power of genome modification would probably be increased.
T24 247-501 Sentence denotes What concerns us more is that the 2019-nCoV, by the process of modification of genome structure, might become more and more fitted to humans to profoundly affect those who have already escaped – children and young people without a pre-existing condition.
T25 502-656 Sentence denotes No one can tell how much time it takes to reach a new level of perfection, and that the development of vaccines for active immunization is a long process.
T26 657-757 Sentence denotes Moreover, most of the best available anti-viral agents are not helpful in the treatment of COVID-19.
T27 758-1049 Sentence denotes A randomized controlled trial of 199 hospitalized adults with confirmed COVID-19 demonstrated no actual difference between patients who received lopinavir-ritonavir and patients who received standard care alone in clinical improvement, death rate, and positive virus test rate at day 28 [1].

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
88 57-65 Disease denotes COVID-19 MESH:C000657245
89 155-163 Disease denotes COVID-19 MESH:C000657245
84 281-290 Species denotes 2019-nCoV Tax:2697049
85 381-387 Species denotes humans Tax:9606
86 442-450 Species denotes children Tax:9606
87 461-467 Species denotes people Tax:9606
101 748-756 Disease denotes COVID-19 MESH:C000657245
102 830-838 Disease denotes COVID-19 MESH:C000657245
98 881-889 Species denotes patients Tax:9606
100 903-922 Chemical denotes lopinavir-ritonavir MESH:C558899
99 927-935 Species denotes patients Tax:9606
103 994-999 Disease denotes death MESH:D003643
104 1112-1120 Disease denotes COVID-19 MESH:C000657245
105 1186-1194 Disease denotes COVID-19 MESH:C000657245

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T266 0-1 CD denotes 1
T267 3-15 NN denotes Introduction
T268 16-23 JJ denotes Several
T269 24-35 NNS denotes generations
T270 36-40 VBP denotes have
T271 41-45 VBN denotes been
T272 46-53 VBN denotes exposed
T273 54-56 TO denotes to
T274 57-65 NN denotes COVID-19
T275 66-71 IN denotes under
T276 72-81 JJ denotes different
T277 82-92 NNS denotes conditions
T278 93-95 IN denotes of
T279 96-100 NN denotes life
T280 101-103 IN denotes at
T281 104-111 VBG denotes varying
T282 112-121 NNS denotes locations
T283 122-128 IN denotes around
T284 129-132 DT denotes the
T285 133-138 NN denotes world
T286 140-142 RB denotes As
T287 143-147 RB denotes long
T288 148-150 IN denotes as
T289 151-154 DT denotes the
T290 155-163 NN denotes COVID-19
T291 164-173 VBZ denotes continues
T292 174-176 TO denotes to
T293 177-183 VB denotes spread
T294 183-184 -COMMA- denotes ,
T295 185-188 PRP-DOLLAR- denotes its
T296 189-194 NN denotes power
T297 195-197 IN denotes of
T298 198-204 NN denotes genome
T299 205-217 NN denotes modification
T300 218-223 MD denotes would
T301 224-232 RB denotes probably
T302 233-235 VB denotes be
T303 236-245 VBN denotes increased
T304 247-251 WP denotes What
T305 252-260 VBZ denotes concerns
T306 261-263 PRP denotes us
T307 264-268 RBR denotes more
T308 269-271 VBZ denotes is
T309 272-276 IN denotes that
T310 277-280 DT denotes the
T311 281-290 NN denotes 2019-nCoV
T312 290-291 -COMMA- denotes ,
T313 292-294 IN denotes by
T314 295-298 DT denotes the
T315 299-306 NN denotes process
T316 307-309 IN denotes of
T317 310-322 NN denotes modification
T318 323-325 IN denotes of
T319 326-332 NN denotes genome
T320 333-342 NN denotes structure
T321 342-343 -COMMA- denotes ,
T322 344-349 MD denotes might
T323 350-356 VB denotes become
T324 357-361 RBR denotes more
T325 362-365 CC denotes and
T326 366-370 RBR denotes more
T327 371-377 VBN denotes fitted
T328 378-380 TO denotes to
T329 381-387 NNS denotes humans
T330 388-390 TO denotes to
T331 391-401 RB denotes profoundly
T332 402-408 VB denotes affect
T333 409-414 DT denotes those
T334 415-418 WP denotes who
T335 419-423 VBP denotes have
T336 424-431 RB denotes already
T337 432-439 VBN denotes escaped
T338 440-441 NN denotes –
T339 442-450 NNS denotes children
T340 451-454 CC denotes and
T341 455-460 JJ denotes young
T342 461-467 NNS denotes people
T343 468-475 IN denotes without
T344 476-477 DT denotes a
T345 478-490 JJ denotes pre-existing
T346 491-500 NN denotes condition
T347 502-504 DT denotes No
T348 505-508 NN denotes one
T349 509-512 MD denotes can
T350 513-517 VB denotes tell
T351 518-521 WRB denotes how
T352 522-526 JJ denotes much
T353 527-531 NN denotes time
T354 532-534 PRP denotes it
T355 535-540 VBZ denotes takes
T356 541-543 TO denotes to
T357 544-549 VB denotes reach
T358 550-551 DT denotes a
T359 552-555 JJ denotes new
T360 556-561 NN denotes level
T361 562-564 IN denotes of
T362 565-575 NN denotes perfection
T363 575-576 -COMMA- denotes ,
T364 577-580 CC denotes and
T365 581-585 IN denotes that
T366 586-589 DT denotes the
T367 590-601 NN denotes development
T368 602-604 IN denotes of
T369 605-613 NNS denotes vaccines
T370 614-617 IN denotes for
T371 618-624 JJ denotes active
T372 625-637 NN denotes immunization
T373 638-640 VBZ denotes is
T374 641-642 DT denotes a
T375 643-647 JJ denotes long
T376 648-655 NN denotes process
T377 657-665 RB denotes Moreover
T378 665-666 -COMMA- denotes ,
T379 667-671 JJS denotes most
T380 672-674 IN denotes of
T381 675-678 DT denotes the
T382 679-683 JJS denotes best
T383 684-693 JJ denotes available
T384 694-704 JJ denotes anti-viral
T385 705-711 NNS denotes agents
T386 712-715 VBP denotes are
T387 716-719 RB denotes not
T388 720-727 JJ denotes helpful
T389 728-730 IN denotes in
T390 731-734 DT denotes the
T391 735-744 NN denotes treatment
T392 745-747 IN denotes of
T393 748-756 NN denotes COVID-19
T394 758-759 DT denotes A
T395 760-770 VBN denotes randomized
T396 771-781 VBN denotes controlled
T397 782-787 NN denotes trial
T398 788-790 IN denotes of
T399 791-794 CD denotes 199
T400 795-807 VBN denotes hospitalized
T401 808-814 NNS denotes adults
T402 815-819 IN denotes with
T403 820-829 VBN denotes confirmed
T404 830-838 NN denotes COVID-19
T405 839-851 VBD denotes demonstrated
T406 852-854 DT denotes no
T407 855-861 JJ denotes actual
T408 862-872 NN denotes difference
T409 873-880 IN denotes between
T410 881-889 NNS denotes patients
T411 890-893 WP denotes who
T412 894-902 VBD denotes received
T413 903-922 NN denotes lopinavir-ritonavir
T414 923-926 CC denotes and
T415 927-935 NNS denotes patients
T416 936-939 WP denotes who
T417 940-948 VBD denotes received
T418 949-957 JJ denotes standard
T419 958-962 NN denotes care
T420 963-968 RB denotes alone
T421 969-971 IN denotes in
T422 972-980 JJ denotes clinical
T423 981-992 NN denotes improvement
T424 992-993 -COMMA- denotes ,
T425 994-999 NN denotes death
T426 1000-1004 NN denotes rate
T427 1004-1005 -COMMA- denotes ,
T428 1006-1009 CC denotes and
T429 1010-1018 JJ denotes positive
T430 1019-1024 NN denotes virus
T431 1025-1029 NN denotes test
T432 1030-1034 NN denotes rate
T433 1035-1037 IN denotes at
T434 1038-1041 NN denotes day
T435 1042-1044 CD denotes 28
T436 1045-1046 -LRB- denotes [
T437 1046-1047 CD denotes 1
T438 1047-1048 -RRB- denotes ]
T439 1050-1054 RB denotes Here
T440 1055-1057 PRP denotes we
T441 1058-1064 VBP denotes review
T442 1065-1077 JJ denotes intermediate
T443 1078-1088 NNS denotes indicators
T444 1089-1091 IN denotes of
T445 1092-1095 DT denotes the
T446 1096-1108 NN denotes pathogenesis
T447 1109-1111 IN denotes of
T448 1112-1120 NN denotes COVID-19
T449 1121-1125 WDT denotes that
T450 1126-1130 VBP denotes have
T451 1131-1134 DT denotes the
T452 1135-1144 NN denotes potential
T453 1145-1147 IN denotes of
T454 1148-1153 VBG denotes being
T455 1154-1164 VBN denotes considered
T456 1165-1168 IN denotes for
T457 1169-1172 DT denotes the
T458 1173-1182 NN denotes treatment
T459 1183-1185 IN denotes of
T460 1186-1194 NN denotes COVID-19
R304 T311 T310 arg1Of 2019-nCoV,the
R305 T327 T312 arg1Of fitted,","
R306 T327 T313 arg1Of fitted,by
R307 T315 T313 arg2Of process,by
R308 T315 T314 arg1Of process,the
R309 T315 T316 arg1Of process,of
R310 T317 T316 arg2Of modification,of
R311 T317 T318 arg1Of modification,of
R358 T360 T359 arg1Of level,new
R359 T360 T361 arg1Of level,of
R360 T362 T361 arg2Of perfection,of
R361 T361 T363 arg1Of of,","
R454 T458 T456 arg2Of treatment,for
R455 T458 T457 arg1Of treatment,the
R456 T458 T459 arg1Of treatment,of
R457 T460 T459 arg2Of COVID-19,of
R258 T267 T266 arg1Of Introduction,1
R259 T269 T268 arg1Of generations,Several
R260 T269 T270 arg1Of generations,have
R261 T272 T270 arg2Of exposed,have
R262 T269 T271 arg1Of generations,been
R263 T272 T271 arg2Of exposed,been
R264 T269 T272 arg2Of generations,exposed
R265 T272 T273 arg1Of exposed,to
R266 T274 T273 arg2Of COVID-19,to
R267 T272 T275 arg1Of exposed,under
R268 T277 T275 arg2Of conditions,under
R269 T277 T276 arg1Of conditions,different
R270 T277 T278 arg1Of conditions,of
R271 T279 T278 arg2Of life,of
R272 T272 T280 arg1Of exposed,at
R273 T282 T280 arg2Of locations,at
R274 T282 T281 arg1Of locations,varying
R275 T282 T283 arg1Of locations,around
R276 T285 T283 arg2Of world,around
R277 T285 T284 arg1Of world,the
R278 T287 T286 arg1Of long,As
R279 T303 T287 arg1Of increased,long
R280 T288 T287 arg2Of as,long
R281 T291 T288 arg2Of continues,as
R282 T290 T289 arg1Of COVID-19,the
R283 T290 T291 arg1Of COVID-19,continues
R284 T293 T291 arg2Of spread,continues
R285 T293 T292 arg1Of spread,to
R286 T290 T293 arg1Of COVID-19,spread
R287 T303 T294 arg1Of increased,","
R288 T296 T295 arg1Of power,its
R289 T296 T297 arg1Of power,of
R290 T299 T297 arg2Of modification,of
R291 T299 T298 arg1Of modification,genome
R292 T296 T300 arg1Of power,would
R293 T303 T300 arg2Of increased,would
R294 T303 T301 arg1Of increased,probably
R295 T296 T302 arg1Of power,be
R296 T303 T302 arg2Of increased,be
R297 T296 T303 arg2Of power,increased
R298 T304 T305 arg1Of What,concerns
R299 T306 T305 arg2Of us,concerns
R300 T307 T305 arg3Of more,concerns
R301 T304 T308 arg1Of What,is
R302 T327 T308 arg2Of fitted,is
R303 T327 T309 arg1Of fitted,that
R312 T320 T318 arg2Of structure,of
R313 T320 T319 arg1Of structure,genome
R314 T327 T321 arg1Of fitted,","
R315 T311 T322 arg1Of 2019-nCoV,might
R316 T327 T322 arg2Of fitted,might
R317 T311 T323 arg1Of 2019-nCoV,become
R318 T327 T323 arg2Of fitted,become
R319 T327 T324 arg1Of fitted,more
R320 T324 T325 arg1Of more,and
R321 T326 T325 arg2Of more,and
R322 T327 T326 arg1Of fitted,more
R323 T311 T327 arg2Of 2019-nCoV,fitted
R324 T327 T328 arg1Of fitted,to
R325 T329 T328 arg2Of humans,to
R326 T332 T330 arg1Of affect,to
R327 T329 T330 modOf humans,to
R328 T332 T331 arg1Of affect,profoundly
R329 T333 T332 arg2Of those,affect
R330 T333 T334 arg1Of those,who
R331 T333 T335 arg1Of those,have
R332 T337 T335 arg2Of escaped,have
R333 T337 T336 arg1Of escaped,already
R334 T333 T337 arg1Of those,escaped
R335 T340 T337 arg2Of and,escaped
R336 T339 T338 arg1Of children,–
R337 T339 T340 arg1Of children,and
R338 T342 T340 arg2Of people,and
R339 T342 T341 arg1Of people,young
R340 T337 T343 arg1Of escaped,without
R341 T346 T343 arg2Of condition,without
R342 T346 T344 arg1Of condition,a
R343 T346 T345 arg1Of condition,pre-existing
R344 T348 T347 arg1Of one,No
R345 T348 T349 arg1Of one,can
R346 T350 T349 arg2Of tell,can
R347 T348 T350 arg1Of one,tell
R348 T351 T350 arg2Of how,tell
R349 T352 T351 arg1Of much,how
R350 T355 T352 arg1Of takes,much
R351 T352 T353 arg1Of much,time
R352 T354 T355 arg1Of it,takes
R353 T357 T355 arg2Of reach,takes
R354 T357 T356 arg1Of reach,to
R355 T354 T357 arg1Of it,reach
R356 T360 T357 arg2Of level,reach
R357 T360 T358 arg1Of level,a
R362 T361 T364 arg1Of of,and
R363 T365 T364 arg2Of that,and
R364 T360 T365 arg1Of level,that
R365 T373 T365 arg2Of is,that
R366 T367 T366 arg1Of development,the
R367 T367 T368 arg1Of development,of
R368 T369 T368 arg2Of vaccines,of
R369 T367 T370 arg1Of development,for
R370 T372 T370 arg2Of immunization,for
R371 T372 T371 arg1Of immunization,active
R372 T367 T373 arg1Of development,is
R373 T376 T373 arg2Of process,is
R374 T376 T374 arg1Of process,a
R375 T376 T375 arg1Of process,long
R376 T386 T377 arg1Of are,Moreover
R377 T386 T378 arg1Of are,","
R378 T379 T380 arg1Of most,of
R379 T385 T380 arg2Of agents,of
R380 T385 T381 arg1Of agents,the
R381 T383 T382 arg1Of available,best
R382 T385 T383 arg1Of agents,available
R383 T385 T384 arg1Of agents,anti-viral
R384 T379 T386 arg1Of most,are
R385 T388 T386 arg2Of helpful,are
R386 T386 T387 arg1Of are,not
R387 T379 T388 arg1Of most,helpful
R388 T386 T389 arg1Of are,in
R389 T391 T389 arg2Of treatment,in
R390 T391 T390 arg1Of treatment,the
R391 T391 T392 arg1Of treatment,of
R392 T393 T392 arg2Of COVID-19,of
R393 T397 T394 arg1Of trial,A
R394 T397 T395 arg2Of trial,randomized
R395 T397 T396 arg2Of trial,controlled
R396 T397 T398 arg1Of trial,of
R397 T401 T398 arg2Of adults,of
R398 T401 T399 arg1Of adults,199
R399 T401 T400 arg2Of adults,hospitalized
R400 T401 T402 arg1Of adults,with
R401 T404 T402 arg2Of COVID-19,with
R402 T404 T403 arg2Of COVID-19,confirmed
R403 T397 T405 arg1Of trial,demonstrated
R404 T408 T405 arg2Of difference,demonstrated
R405 T408 T406 arg1Of difference,no
R406 T408 T407 arg1Of difference,actual
R407 T408 T409 arg1Of difference,between
R408 T410 T409 arg2Of patients,between
R409 T410 T411 arg1Of patients,who
R410 T410 T412 arg1Of patients,received
R411 T414 T412 arg2Of and,received
R412 T413 T414 arg1Of lopinavir-ritonavir,and
R413 T415 T414 arg2Of patients,and
R414 T410 T416 arg1Of patients,who
R415 T410 T417 arg1Of patients,received
R416 T419 T417 arg2Of care,received
R417 T419 T418 arg1Of care,standard
R418 T419 T420 arg1Of care,alone
R419 T417 T421 arg1Of received,in
R420 T428 T421 arg2Of and,in
R421 T423 T422 arg1Of improvement,clinical
R422 T423 T424 arg1Of improvement,","
R423 T426 T424 arg2Of rate,","
R424 T426 T425 arg1Of rate,death
R425 T428 T427 arg1Of and,","
R426 T424 T428 arg1Of ",",and
R427 T432 T428 arg2Of rate,and
R428 T432 T429 arg1Of rate,positive
R429 T432 T430 arg1Of rate,virus
R430 T432 T431 arg1Of rate,test
R431 T432 T433 arg1Of rate,at
R432 T434 T433 arg2Of day,at
R433 T434 T435 arg1Of day,28
R434 T417 T436 arg1Of received,[
R435 T437 T436 arg2Of 1,[
R436 T438 T436 arg3Of ],[
R437 T441 T439 arg1Of review,Here
R438 T440 T441 arg1Of we,review
R439 T443 T441 arg2Of indicators,review
R440 T443 T442 arg1Of indicators,intermediate
R441 T443 T444 arg1Of indicators,of
R442 T446 T444 arg2Of pathogenesis,of
R443 T446 T445 arg1Of pathogenesis,the
R444 T446 T447 arg1Of pathogenesis,of
R445 T448 T447 arg2Of COVID-19,of
R446 T443 T449 arg1Of indicators,that
R447 T443 T450 arg1Of indicators,have
R448 T452 T450 arg2Of potential,have
R449 T452 T451 arg1Of potential,the
R450 T452 T453 arg1Of potential,of
R451 T455 T453 arg2Of considered,of
R452 T455 T454 arg2Of considered,being
R453 T455 T456 arg1Of considered,for

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T3 994-999 http://purl.obolibrary.org/obo/GO_0016265 denotes death
T4 1096-1108 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T8 198-204 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116
T9 326-332 Body_part denotes genome http://purl.org/sig/ont/fma/fma84116

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T21 57-65 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T22 155-163 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T23 748-756 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T24 830-838 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T25 1112-1120 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T26 1186-1194 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T2 1096-1108 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T2 1096-1108 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T21 0-15 Sentence denotes 1 Introduction
T22 16-139 Sentence denotes Several generations have been exposed to COVID-19 under different conditions of life at varying locations around the world.
T23 140-246 Sentence denotes As long as the COVID-19 continues to spread, its power of genome modification would probably be increased.
T24 247-501 Sentence denotes What concerns us more is that the 2019-nCoV, by the process of modification of genome structure, might become more and more fitted to humans to profoundly affect those who have already escaped – children and young people without a pre-existing condition.
T25 502-656 Sentence denotes No one can tell how much time it takes to reach a new level of perfection, and that the development of vaccines for active immunization is a long process.
T26 657-757 Sentence denotes Moreover, most of the best available anti-viral agents are not helpful in the treatment of COVID-19.
T27 758-1049 Sentence denotes A randomized controlled trial of 199 hospitalized adults with confirmed COVID-19 demonstrated no actual difference between patients who received lopinavir-ritonavir and patients who received standard care alone in clinical improvement, death rate, and positive virus test rate at day 28 [1].
T28 1050-1195 Sentence denotes Here we review intermediate indicators of the pathogenesis of COVID-19 that have the potential of being considered for the treatment of COVID-19.